Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia. Xu J, Peng J, Sun S, Wang D, et al. Br J Haematol 2024;204:2301-2318.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu J, Peng J, Sun S, Wang D, et al. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia. Br J Haematol 2024;204:2301-2318.
PMID: 38685813